Ubs Asset Management Americas Inc ALNYLAM PHARMACEUTICALS INC Transaction History

Ubs Asset Management Americas Inc

  • $417 Billion
  • Q4 2024
Number of Shares
1,435,000
Previous 1,480,000 3.04%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
N/A
-45,000 Reduced 3.04%
1,435,000 $0
Q3 2024

Nov 14, 2024
SELL
N/A
-450,000 Reduced 23.32%
1,480,000 $0
Q2 2024

Aug 13, 2024
SELL
N/A
-68,670,000 Reduced 97.27%
1,930,000 $0
Q1 2024

May 15, 2024
SELL
N/A
-4,000,000 Reduced 5.36%
70,600,000 $0
Q3 2023

Nov 13, 2023
BUY
N/A
74,600,000 New
74,600,000 $0
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email